Every Form 4 that Marsh & Mclennan (MRSH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow MRSH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MRSH filings page.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that Katherine Brennan, its Senior Vice President and General Counsel, exercised employee stock options covering 1,197 shares of common stock on September 2, 2026 at an exercise price of $83.046 per share, then sold 1,197 shares of common stock at $187.899 per share the same day. The underlying options, granted on February 21, 2018 and vesting annually from 2019 through 2022, are now fully exercised with no shares remaining from that grant, and no Rule 10b5-1 trading plan is reported for these transactions.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that President and CEO John Q. Doyle exercised stock options for 16,656 shares of common stock on September 2, 2026 at an exercise price of $73.195 per share, converting previously granted options into shares.
On the same date, he sold 16,656 shares of common stock at a reported price of $188.51 per share. The filing states that these transactions were effected pursuant to a previously adopted Rule 10b5-1 trading plan, indicating they were pre-arranged rather than opportunistic.
Marsh & McLennan Companies, Inc. (MRSH) director Morton O. Schapiro reported two equity compensation transactions involving restricted stock units that convert into common stock on a 1-for-1 basis. On August 15, 2026, he received 218.9 restricted stock units as a grant of director fees under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $188.445 per unit. On August 14, 2026, he acquired an additional 473.39 restricted stock units through dividend equivalents credited to his account under the same plan at a reference price of $189.15 per unit. Both awards are reported as directly owned and are derivative securities linked to common stock.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Anthony Anderson reported an other acquisition of derivative securities tied to common stock. On 2026-08-14, he acquired 89.41 Restricted Stock Units under the Directors Stock Compensation Plan through dividend equivalents, which convert into common stock on a 1-for-1 basis. Following this transaction, his directly held derivative position under this plan totals 17,171.56 units. These RSUs are reported at a reference value of $189.15 per unit, and the filing does not indicate use of a Rule 10b5-1 trading plan.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Deborah C. Hopkins reported an acquisition of derivative equity under the company’s directors stock plan. On 2026-08-14, she acquired 112.08 Restricted Stock Units labeled "Restricted Stk. Units-Dir. Stk. Plan," which convert into Marsh & McLennan common stock on a 1-for-1 basis. These units were credited as dividend equivalents under the Marsh & McLennan Companies Directors Stock Compensation Plan. Following this transaction, Hopkins directly holds a reported total of 21,526.64 restricted stock units linked to common stock.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported an acquisition of 47.56 restricted stock units under the Directors Stock Compensation Plan on 2026-08-14. These units were acquired as dividend equivalents and each unit converts into one share of common stock on a 1-for-1 basis, bringing her directly held restricted stock unit balance to 9,133.91 units.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Lloyd M. Yates reported two acquisitions of restricted stock units under the company’s Directors Stock Compensation Plan. On August 15, 2026, he received 223.73 RSUs tied to director fees, and on August 14, 2026, he received 64.85 RSUs as dividend equivalents. Each unit converts into one share of common stock.
MARSH & MCLENNAN COMPANIES, INC. (symbol MRSH) reports that director Jane H Lute received equity-based compensation in the form of restricted stock units under the company’s Directors Stock Compensation Plan. On 2026-08-15, she was granted 144.27 restricted stock units, and on 2026-08-14 she acquired an additional 46.64 units credited as dividend equivalents. Each unit converts into one share of common stock according to the plan terms.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Jan Siegmund reported an acquisition of 12.03 Restricted Stock Units under the Directors Stock Compensation Plan on 2026-08-14, valued at $189.15 per unit. These RSUs were credited as dividend equivalents and are convertible into an equal number of common shares on a 1-for-1 basis.
Following this transaction, Siegmund directly holds a total of 2,310.27 Restricted Stock Units, each representing the right to receive one share of Marsh & McLennan common stock in the future.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) director Steven A. Mills reported a grant of 194 shares of common stock on 2026-08-15, acquired as part of director fees under the Marsh & McLennan Companies Directors Stock Compensation Plan at a value of $188.445 per share. Following this award, Mills directly holds 5,951.75 shares and indirectly holds 47,553 shares through a trust.
MARSH & MCLENNAN COMPANIES, INC. (MRSH) reported that director Bruce D. Broussard received a grant of 192 shares of Common Stock on 2026-08-15. The award, valued at $188.445 per share, was acquired as part of director fees under the Marsh & McLennan Companies Directors Stock Compensation Plan. Following this grant, Broussard directly holds 1,617 shares of MRSH common stock.
Marsh & McLennan Companies, Inc. Chief Marketing Officer John Jude Jones reported selling 6,500 shares of common stock on 2026-08-06 in an open-market or private transaction at $191.9574 per share. After this sale, he holds 1,478 shares directly and 1,862.024 shares indirectly through the MMC 401(k) Savings & Investment Plan. These transactions were not reported as made under a Rule 10b5-1 trading plan.
Paul Beswick, SVP and Chief Information Officer of Marsh & McLennan Companies, reported selling 713 shares of Common Stock on 29 July 2026 at $198 per share. The sale was executed under a previously adopted Rule 10b5-1 trading plan, leaving him with 16,376 shares of direct holdings.
Marsh & McLennan Companies’ Chief Client Officer South Martin sold 7,100 shares of Common Stock on July 28, 2026 at an average price of $189.9925 per share in an open market or private transaction.
After this sale, Martin directly owns 16,631.709 shares, including 81.17 shares acquired through the Employee Stock Purchase Plan for the quarters ended March 31 and June 30, 2026.
Marsh & McLennan Companies director Lloyd M. Yates sold 12000 shares of Common Stock on July 23, 2026 at $175.6500 per share in an open-market or private transaction. After this sale, he directly owned 12000.7500 shares, and the trade was not made under a Rule 10b5-1 plan.
Marsh & McLennan Companies President and CEO John Q. Doyle reported an option exercise and related share sale. He exercised options to acquire 16,656 shares of Common Stock at $73.195 per share, then sold 16,656 shares at $161.71 per share in an open‑market transaction.
The filing notes that the sale was effected under a pre‑arranged Rule 10b5‑1 trading plan, meaning it was scheduled in advance. After these transactions, Doyle continues to hold over 100,000 shares of Marsh & McLennan stock directly.
Marsh & McLennan Companies director Morton O. Schapiro received an annual equity grant of 1,349.82 restricted stock units. The award, made under the Marsh & McLennan Companies Directors Stock Compensation Plan, is valued at a reference price of $159.28 per unit and converts into common stock on a 1-for-1 basis.
Following this grant, Schapiro directly holds 90,445.40 shares of common stock, including the underlying shares from these units. This is a compensation-related award rather than an open-market purchase or sale.
Marsh & McLennan Companies director Anthony Anderson received an annual equity grant of 1,349.82 restricted stock units. The award was made under the Marsh & McLennan Companies Directors Stock Compensation Plan and is classified as a grant or award acquisition, not an open-market purchase.
The restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis, aligning the director’s compensation with future share performance. Following this grant, Anderson holds a total of 17,082.15 units directly, reinforcing his equity stake in the company.
Marsh & McLennan Companies director Deborah C. Hopkins received an annual equity grant under the company’s Directors Stock Compensation Plan. She was awarded 1,349.82 restricted stock units that convert into common stock on a 1-for-1 basis, reflecting a reference price of $159.28 per share. Following this grant, she directly holds 21,414.56 shares-equivalent of common stock. This is a compensation-related award, not an open-market purchase or sale.
Marsh & McLennan Companies director Tamara Ingram received an annual stock award in the form of 1,349.82 restricted stock units under the company’s Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis.
After this grant, Ingram directly holds 9,086.35 shares-related units, reflecting routine, compensation-based equity rather than an open-market purchase or sale.
Marsh & McLennan Companies director Lloyd M. Yates received an annual stock award of restricted stock units. On June 1, 2026, he was granted 1,349.82 restricted stock units under the Directors Stock Compensation Plan. These units convert into common stock on a 1-for-1 basis, bringing his directly held equity-related position reported in this filing to 12,390.99 shares on a converted basis. This is a compensation-related equity grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies director Jane H. Lute received an equity award through the company’s director stock plan. She was granted 1,349.82 restricted stock units on June 1, 2026, which convert into common stock on a 1-for-1 basis. Following this grant, she holds 8,911.69 derivative shares linked to common stock. The award is classified as a grant or other acquisition, reflecting routine director compensation rather than an open‑market trade.
Marsh & McLennan Companies director Jan Siegmund received an annual stock award of 1,349.82 restricted stock units on Marsh & McLennan common stock. The units were valued at $159.28 per underlying share and convert into common stock on a 1-for-1 basis.
Following this grant, Siegmund directly holds 2,298.24 restricted stock units linked to Marsh & McLennan common stock. This is a compensation-related award rather than an open-market purchase or sale.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills reported an annual stock award, not an open‑market trade. He received a grant of 1,349 shares of common stock at $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan. After this compensation grant, he holds 5,757.75 shares directly and 47,553 shares indirectly through a trust.
HANWAY H EDWARD reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director H. Edward Hanway received an annual stock award of 1,349 shares of Common Stock. The award was granted on June 1, 2026 under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
After this grant, Hanway directly holds a total of 36,867.7 shares of Marsh & McLennan common stock. This is a compensation-related equity award, not an open‑market purchase or sale.
Hartmann Judith reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Judith Hartmann received an annual stock award of 1,349 shares of Common Stock. The shares were granted on June 1, 2026 at a reported price of $159.28 per share under the Marsh & McLennan Companies Directors Stock Compensation Plan.
Following this grant, Hartmann directly holds 4,323 shares of the company’s common stock. This is a compensation-related award rather than an open-market purchase, so it reflects standard director remuneration rather than a trading decision based on the share price.
Marsh & McLennan Companies director Peter Harrison reported compensation-related stock transactions. He received an annual stock award of 1,349 shares of common stock under the Marsh & McLennan Companies Directors Stock Compensation Plan at a reference price of $159.28 per share.
To cover applicable taxes on shares acquired with director fees under the same plan, 103.39 shares of common stock were withheld in a tax-withholding disposition. After these transactions and receipt of cash in lieu of a fractional share, Harrison directly holds 1,349.82 shares of Marsh & McLennan common stock.
BROUSSARD BRUCE D reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Bruce D. Broussard received an annual stock award of 1,349 shares of common stock on June 1, 2026 under the company’s Directors Stock Compensation Plan. The grant was valued at $159.28 per share and increased his direct holdings to 1,425 shares.
Marsh & McLennan Companies director Morton O. Schapiro reported routine equity compensation activity. On May 15, 2026, he received 256.85 restricted stock units under the Marsh & McLennan Companies Directors Stock Compensation Plan, valued at $160.60 per unit. A separate adjustment of 495.08 restricted stock units reflects dividend equivalents credited under the same plan. Each restricted stock unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis, and Schapiro now holds more than 88,000 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. director Deborah C. Hopkins reported an administrative Form 4 update related to her director stock compensation. On 2026-05-15, 111.82 restricted stock units were credited to her account at a reference price of $160.60 per unit through dividend equivalents.
These restricted stock units convert into Marsh & McLennan common stock on a 1-for-1 basis. Following this transaction, Hopkins directly holds a total of 20,064.74 restricted stock units under the directors stock compensation plan.
MARSH & MCLENNAN COMPANIES, INC. director Tamara Ingram reported a routine compensation-related adjustment to her equity holdings. She received 43.11 restricted stock units under the Directors Stock Compensation Plan, credited as dividend equivalents and tied to the company’s common stock on a 1-for-1 basis.
Following this transaction, Ingram holds a total of 7,736.53 restricted stock units directly. The filing does not reflect any open-market purchase or sale of Marsh & McLennan common shares, but rather an administrative update to her stock-based compensation balance.
Marsh & McLennan Companies director Lloyd M. Yates reported routine stock-based compensation activity involving restricted stock units that convert into common stock on a 1-for-1 basis. He received a grant of 225.720 restricted stock units in connection with director fees under the Directors Stock Compensation Plan.
In a separate restructuring-type entry, 60.270 restricted stock units were acquired through dividend equivalents credited to his account. Following these transactions, Yates directly holds about 11,041.170 restricted stock units, reflecting ongoing equity-based compensation rather than open-market trading.
Lute Jane H reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies director Jane H. Lute reported routine equity compensation activity. She received 169.29 restricted stock units under the Directors Stock Compensation Plan at a reference price of $160.60 per unit. An additional 41.2 units were credited as dividend equivalents, all convertible into common stock on a 1-for-1 basis.
Marsh & McLennan director Jan Siegmund reported an internal equity adjustment involving 5.29 restricted stock units credited as dividend equivalents under the Directors Stock Compensation Plan. These units convert to common stock on a 1‑for‑1 basis, increasing his restricted stock unit holdings to 948.42.
MILLS STEVEN A reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. director Steven A. Mills received an award of 264 shares of common stock at $160.60 per share as part of his director fees under the company’s Directors Stock Compensation Plan. Following this grant, he holds 4,408.75 shares directly and 47,553 shares indirectly through a trust.
MARSH & MCLENNAN COMPANIES director Anthony Anderson reported an internal adjustment involving 87.67 restricted stock units under the Directors Stock Compensation Plan. These units were credited as dividend equivalents and each converts into one share of common stock. Following this routine plan transaction, Anderson holds 15,732.33 units directly.
Marsh & McLennan Companies reported that Dean Michael Klisura, President & CEO of Guy Carpenter, received a grant of 14,907 restricted stock units. Each unit converts into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028 and May 15, 2029. Following this award, Klisura is reported as directly holding 14,907 restricted stock units tied to common stock.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones received a grant of 5,963 restricted stock units as equity compensation. Each unit converts into one share of common stock. These RSUs vest in three equal annual installments on May 15, 2027, 2028 and 2029, leaving him with 5,963 units reported after this grant.
Beswick Paul reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies reported that SVP and Chief Information Officer Paul Beswick received a grant of 14,907 restricted stock units. These RSUs represent future rights to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, encouraging longer-term alignment between the executive and shareholders. All 14,907 RSUs are reported as directly owned following this grant.
South Martin reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies’ Chief Client Officer South Martin received a grant of 5,963 restricted stock units. These units represent the right to receive an equal number of Marsh & McLennan common shares on a 1-for-1 basis, subject to vesting conditions.
The restricted stock units vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029. This is a compensation-related award rather than an open-market stock purchase or sale, and after this grant Martin holds 5,963 restricted stock units directly.
MCGIVNEY MARK C reported acquisition or exercise transactions in this Form 4 filing.
Marsh & McLennan Companies executive Mark C. McGivney received a grant of 59,627 restricted stock units. These units were awarded as compensation and are convertible into an equal number of Marsh & McLennan common shares on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028, and 2029, subject to continued service and any plan terms. Following this grant, McGivney holds 59,627 restricted stock units directly, with no open-market buying or selling reported in this filing.
MARSH & MCLENNAN COMPANIES, INC. reported that executive Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 8,945 restricted stock units (RSUs) on Marsh & McLennan common stock as equity-based compensation.
The RSUs convert into common stock on a 1-for-1 basis and are scheduled to vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this award, Studer holds a total of 14,711 RSUs directly. This is a compensation-related grant, not an open-market share purchase or sale.
Marsh & McLennan Companies President and CEO John Q. Doyle received a grant of 89,441 restricted stock units as equity compensation. These units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028, and 2029.
Marsh & McLennan Companies reported that Patrick Tomlinson, President and CEO of Mercer, received a grant of 14,907 restricted stock units. These units convert into Marsh & McLennan common stock on a 1-for-1 basis.
The restricted stock units vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, Tomlinson holds 19,761 restricted stock units directly.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and Chief People Officer Carmen Fernandez received a grant of 5,963 restricted stock units.
The units convert into common stock on a 1-for-1 basis and vest in three equal annual installments on May 15, 2027, 2028 and 2029. Following this grant, she holds 5,963 restricted stock units directly.
Brennan Katherine reported acquisition or exercise transactions in this Form 4 filing.
MARSH & MCLENNAN COMPANIES, INC. reported that SVP and General Counsel Katherine Brennan received a grant of 5,963 Restricted Stock Units. Each unit is convertible into one share of Marsh & McLennan common stock on a 1-for-1 basis.
The RSUs vest in three equal annual installments on May 15, 2027, May 15, 2028, and May 15, 2029, tying the award to multi-year service and performance with the company.
Marsh & McLennan Companies reported that Nicholas Mark Studer, President and CEO of Marsh Risk, received a grant of 5,766 restricted stock units on common stock as equity compensation. The units were granted at no cash cost and convert into common stock on a 1-for-1 basis.
These restricted stock units are scheduled to vest on April 15, 2029. Following this grant, Studer holds 5,766 restricted stock units directly under this award, reflecting a routine long-term incentive grant rather than an open-market share purchase or sale.
Marsh & McLennan Companies executive Patrick Tomlinson, President and CEO of Mercer, reported the vesting and conversion of restricted stock units into common stock. On March 15, 2026, 1,228 RSUs converted into 1,228 shares of common stock on a 1-for-1 basis. Of these, 627 shares were withheld by the company at $172.15 per share to cover applicable taxes, leaving Tomlinson with additional net shares and 4,256 common shares held directly after the transactions. No remaining derivative positions are shown in this filing, indicating a routine compensation-related vesting with tax withholding rather than an open-market trade.
Marsh & McLennan Companies Chief Marketing Officer John Jude Jones reported an open-market sale of common stock. On March 11, 2026, he sold 2,362 shares at an average price of $173.6101 per share. After the sale, he directly held 7,978 shares, with an additional 1,819.885 shares held indirectly through the MMC 401(k) Savings & Investment Plan.
Marsh & McLennan Companies executive Nicholas Mark Studer reported an open-market sale of 3,837 shares of common stock. The shares were sold on March 3, 2026 at an average price of $184.0299 per share to satisfy tax withholding obligations. After this transaction, he directly holds 32,536 shares of the company.